RubenAbbou
Data scientist building ECG algorithms for disease detection. Published in Heart Rhythm and The Lancet.
Selected Work
FDA Breakthrough Device
Cardiac amyloidosis detection from 12-lead ECG
Deep learning for early detection of a rare, often-missed cardiomyopathy. Designated Breakthrough Device by the US FDA.
View work →Heart Rhythm · The Lancet
ECG-AI for structural heart disease screening
Multi-site clinical validation across US and European hospital systems, with peer-reviewed publications.
View work →Currently
Working on
Independent — clinical AI
Based in
Paris, France